Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study
β Scribed by Mike G. Martin; John S. Welch; Jingqin Luo; Matthew J. Ellis; Timothy A. Graubert; Matthew J. Walter
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 157 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract There is now widespread evidence that female survivors of Hodgkin's disease who have been treated with supradiaphragmatic radiotherapy are at an increased risk of breast cancer. Mantle irradiation, which includes irradiation of the mediastinum, conveys a particularly high risk. Previous
Cases of secondary acute myeloid leukemia (AML) occurring after treatment for an Ewing's sarcoma are uncommon. Therapy-related AML with t(8;21) translocation is an entity which has been well characterized. A case of AML-2 with t(8;21) and t(3;15) occurring 4 years after treatment for an Ewing's sarc
## Abstract ## BACKGROUND Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML). ## METHODS This analysis included 272 5βyear AML survivors who participated in the Childhood Cancer
Survival from cancer reflects the aggressiveness of the disease, the effectiveness of treatment and host factors such as age. While hospital-based survival rates are typically used to evaluate the care provided in a particular hospital, populationbased survival reflects the effectiveness of the over